We did not find a significant association between CCDC19 expression levels and patient's age, sex, smoking status, family tumour history, location, tumour size (T classification), lymph node metastasis (N classification), distant metastasis (N classification) or clinical stage (I-II versus III-IV) in 73 NSCLC patients. The gene discussed is CFAP45; the disease is non-small cell lung carcinoma.